Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $3.34 and traded as high as $4.32. ZIVO Bioscience shares last traded at $4.32, with a volume of 1,959 shares trading hands.
ZIVO Bioscience Trading Up 0.4%
The business has a fifty day simple moving average of $3.34 and a 200 day simple moving average of $6.76. The stock has a market capitalization of $17.94 million, a P/E ratio of -0.89 and a beta of 0.07.
ZIVO Bioscience Company Profile
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Read More
- Five stocks we like better than ZIVO Bioscience
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
